IE
ALXO icon

Israel Englander’s ALX Oncology ALXO Stock Holding History

Israel Englander’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Sell
1,543,594
-444,965
-22% -$796K ﹤0.01% 3408
2026
Q1 		$3.99M Sell
1,988,559
-1,216,060
-38% -$2.32M ﹤0.01% 3201
2025
Q4 		$3.62M Buy
3,204,619
+581,758
+22% +$881K ﹤0.01% 3368
2025
Q3 		$4.8M Buy
2,622,861
+2,130,247
+432% +$1.84M ﹤0.01% 3196
2025
Q2 		$204K Sell
492,614
-451,470
-48% -$228K ﹤0.01% 5351
2025
Q1 		$588K Sell
944,084
-1,185,026
-56% -$1.42M ﹤0.01% 4712
2024
Q4 		$3.56M Buy
2,129,110
+126,736
+6% +$195K ﹤0.01% 3143
2024
Q3 		$3.64M Buy
2,002,374
+677,178
+51% +$2.52M ﹤0.01% 3127
2024
Q2 		$7.99M Buy
1,325,196
+1,265,006
+2,102% +$15.6M ﹤0.01% 2296
2024
Q1 		$671K Buy
+60,190
New +$845K ﹤0.01% 4611
2023
Q3 		– Sell
-123,933
Closed -$672K – 6080
2023
Q2 		$931K Buy
123,933
+71,027
+134% +$465K ﹤0.01% 4102
2023
Q1 		$239K Sell
52,906
-34,540
-39% -$262K ﹤0.01% 5066
2022
Q4 		$986K Sell
87,446
-144,716
-62% -$1.63M ﹤0.01% 4180
2022
Q3 		$2.22M Sell
232,162
-197,118
-46% -$2.3M ﹤0.01% 3646
2022
Q2 		$3.47M Buy
429,280
+395,248
+1,161% +$4.3M ﹤0.01% 3159
2022
Q1 		$575K Sell
34,032
-107,686
-76% -$1.84M ﹤0.01% 5020
2021
Q4 		$3.05M Buy
+141,718
New +$6.11M ﹤0.01% 3367
2021
Q3 		– Sell
-12,230
Closed -$669K – 6734
2021
Q2 		$669K Buy
+12,230
New +$732K ﹤0.01% 5035

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Israel Englander's ALXO Position: Q2 2026 in Review

Israel Englander reduced its ALX Oncology (ALXO) stake by 22% in Q2 2026, selling an estimated $796K and leaving 1,543,594 shares worth $3.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Israel Englander first reported a position in ALXO in Q2 2021 and has held it in 18 quarters since. The position peaked at $7.99M in Q2 2024. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Israel Englander held 1,543,594 shares of ALX Oncology worth $3.2M as of Q2 2026.
  • Israel Englander sold 444,965 ALX Oncology shares in Q2 2026, an estimated $796K.
  • ALX Oncology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3408 holding.
  • Israel Englander first reported a position in ALX Oncology in Q2 2021 and has held it in 18 quarters since.
  • Israel Englander's ALX Oncology position peaked at $7.99M in Q2 2024.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.